The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Nektar Therapeutics shares valued at $13,622 were sold by ROBIN HOWARD W on Feb 20 ’24. At $0.68 per share, ROBIN HOWARD W sold 20,033 shares. The insider’s holdings dropped to 879,889 shares worth approximately $1.16 million following the completion of this transaction.
Also, Zalevsky Jonathan sold 9,014 shares, netting a total of over 6,130 in proceeds. Following the sale of shares at $0.68 each, the insider now holds 265,025 shares.
Before that, Wilson Mark Andrew had sold 7,606 shares from its account. In a trade valued at $5,172, the Chief Legal Officer traded Nektar Therapeutics shares for $0.68 each. Upon closing the transaction, the insider’s holdings decreased to 7,606 shares, worth approximately $0.31 million.
Analysts at TD Cowen upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in early November. As of May 10, 2023, Jefferies has increased its “an Underperform” rating to a “Hold” for NKTR. Earlier on February 24, 2023, Jefferies downgraded its rating. Their new recommendation was “an Underperform” for NKTR stock which previously was a “a Hold”.
Analyzing NKTR Stock Performance
During the last five days, there has been a drop of approximately -16.46%. Over the course of the year, Nektar Therapeutics shares have jumped approximately 133.63%. Shares of the company reached a 52-week high of $1.7500 on 04/11/24 and a 52-week low of $0.4800 on 01/18/24. A 50-day SMA is recorded $0.9446, while a 200-day SMA reached $0.6630. Nevertheless, trading volume fell to 3.58 million shares from 1.59 million shares the previous day.
Support And Resistance Levels for Nektar Therapeutics (NKTR)
According to the 24-hour chart, there is a support level at 1.2733, which, if violated, would cause prices to drop to 1.2267. In the upper region, resistance lies at 1.3633. The next price resistance is at 1.4067. RSI (Relative Strength Index) is 58.11 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0749, which suggests the price will decrease in the coming days. Percent R is at 50.58%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
